Table 1.
Demographic, clinical and neuroimaging characteristics of the 125 CADASIL patients enrolled in the study.
Fig 1.
Total number of cerebral microbleeds in 125 CADASIL patients.
Proportions of patients with different numbers of CMB are reported in the bar graph and in the table.
Fig 2.
Examples of different locations of cerebral microbleeds in our sample of CADASIL patients.
T2*-weighted magnetic resonance images showing cerebral microbleeds (white arrows) in infratentorial (A), deep subcortical (B, C) and lobar locations (D).
Table 2.
Correlation between the total number of cerebral microbleeds and demographics, drugs, clinical and other neuroimaging features in 125 CADASIL patients.
Table 3.
Correlation between the number of infratentorial, deep, and lobar cerebral microbleeds and drugs, clinical and other neuroimaging features in 125 CADASIL patients.